The global vascular grafts market size is projected to reach at USD 3.30 billion by 2026 expanding at a CAGR of 6.4%. Endovascular stent grafts dominated the market in 2018 and is expected to be the second fastest-growing segment over the forecast period. Increasing prevalence of cardiovascular aneurysms is the leading cause of rise in demand for endovascular stent grafts. Low levels of physical activity, sedentary lifestyle, and substance abuse are some of the key factors leading to the high prevalence of renal and Cardiac Diseases (CVDs) globally. The impact of these factors is especially high in developed economies, such as North America and Europe. However, it is expected to shift towards emerging regions, such as Asia Pacific and Latin America, owing to changing demographics.
Key factors attributed to higher impact in these countries are increasing prevalence of aforementioned diseases in geriatric population, rising disposable income, and changing lifestyle patterns. Polytetrafluoroethylene (PTFE) raw material segment led the global market in 2018 with a revenue of USD 710.3 million. The segment is anticipated to expand at the fastest CAGR over the forecast period on account of PTFE graft’s advantages, such as protection against delamination and minimal blood loss. Asia Pacific is expected to be the fastest-growing market with a CAGR of 7.5% over the forecast period due to increasing public and private healthcare expenditure and availability of healthcare insurance across urban and rural centers.
Latest posts by Ivy Heffernan (see all)
- Is Trump Planning an Arctic War Through Greenland - August 21, 2019
- Marketers In China Know Shockingly Everything About You – Telemarketing - August 21, 2019
- New Mineralisation Style and Drill Targets – Rumble Resources Ltd (ASX:RTR) - August 21, 2019